Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation
出版年份 2011 全文链接
标题
Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation
作者
关键词
-
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 61, Issue 2, Pages 275-282
出版商
Springer Nature
发表日期
2011-11-26
DOI
10.1007/s00262-011-1164-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Strategies to Overcome Obstacles to Successful Immunotherapy of Melanoma
- (2017) F. Pandolfi et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells
- (2014) P. Sinha et al. JOURNAL OF IMMUNOLOGY
- Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy
- (2011) Eric Tartour et al. CANCER AND METASTASIS REVIEWS
- Regulatory dendritic cells: New targets for cancer immunotherapy
- (2011) Michael R. Shurin et al. CANCER BIOLOGY & THERAPY
- Epidemiologic perspective on immune-surveillance in cancer
- (2011) Daniel W Cramer et al. CURRENT OPINION IN IMMUNOLOGY
- Infection, immunoregulation, and cancer
- (2011) Graham A. W. Rook et al. IMMUNOLOGICAL REVIEWS
- Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
- (2011) Barbara Molon et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inflammation meets cancer, with NF-κB as the matchmaker
- (2011) Yinon Ben-Neriah et al. NATURE IMMUNOLOGY
- Immune parameters affecting the efficacy of chemotherapeutic regimens
- (2011) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
- (2011) C. Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells
- (2011) Ramon Kaneno et al. CELLULAR ONCOLOGY
- Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
- (2010) Suzanne Ostrand-Rosenberg CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
- (2010) Isabel Poschke et al. CANCER RESEARCH
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- Molecular Pathways Linking Inflammation and Cancer
- (2010) A. Mantovani CURRENT MOLECULAR MEDICINE
- Myeloid-derived suppressor cell heterogeneity and subset definition
- (2010) Elisa Peranzoni et al. CURRENT OPINION IN IMMUNOLOGY
- Chemokines in cancer related inflammation
- (2010) Paola Allavena et al. EXPERIMENTAL CELL RESEARCH
- Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor
- (2010) Ilaria Marigo et al. IMMUNITY
- Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
- (2010) S. Nagaraj et al. JOURNAL OF IMMUNOLOGY
- Anti–CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy
- (2010) Margaret K. Callahan et al. SEMINARS IN ONCOLOGY
- New views on natural killer cell-based immunotherapy for melanoma treatment
- (2010) Shannon Burke et al. TRENDS IN IMMUNOLOGY
- Epidemiology of invasive cutaneous melanoma
- (2009) R. M. MacKie et al. ANNALS OF ONCOLOGY
- Modulators of arginine metabolism support cancer immunosurveillance
- (2009) Giusy Capuano et al. BMC IMMUNOLOGY
- Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
- (2009) M. K. Srivastava et al. CANCER RESEARCH
- Activation of p38 Mitogen-Activated Protein Kinase Drives Dendritic Cells to Become Tolerogenic in Ret Transgenic Mice Spontaneously Developing Melanoma
- (2009) F. Zhao et al. CLINICAL CANCER RESEARCH
- Therapeutic targeting of myeloid-derived suppressor cells
- (2009) Stefano Ugel et al. CURRENT OPINION IN PHARMACOLOGY
- Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline
- (2009) Claus Garbe et al. EUROPEAN JOURNAL OF CANCER
- Skin Melanoma Development in ret Transgenic Mice Despite the Depletion of CD25+Foxp3+ Regulatory T Cells in Lymphoid Organs
- (2009) S. Kimpfler et al. JOURNAL OF IMMUNOLOGY
- Chemotherapeutic Agents in Noncytotoxic Concentrations Increase Antigen Presentation by Dendritic Cells via an IL-12-Dependent Mechanism
- (2009) G. V. Shurin et al. JOURNAL OF IMMUNOLOGY
- Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells
- (2009) E. M. Hanson et al. JOURNAL OF IMMUNOLOGY
- Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations
- (2009) Ramon Kaneno et al. Journal of Translational Medicine
- Melanoma-Specific Memory T Cells Are Functionally Active in Ret Transgenic Mice without Macroscopic Tumors
- (2008) V. Umansky et al. CANCER RESEARCH
- Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cells
- (2008) P. Serafini et al. CANCER RESEARCH
- Immune surveillance: a balance between protumor and antitumor immunity
- (2008) Suzanne Ostrand-Rosenberg CURRENT OPINION IN GENETICS & DEVELOPMENT
- The genetics of malignant melanoma
- (2008) Jesus Lomas Frontiers in Bioscience-Landmark
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
- (2008) Pingyan Cheng et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Low-dose Chemotherapeutic Agents Regulate Small Rho GTPase Activity in Dendritic Cells
- (2008) Galina V. Shurin et al. JOURNAL OF IMMUNOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started